Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies

Bone Marrow Transplantation

Volumn 31, Issue 7, 2003, Pages 547-550

  Krishnamurti, L ^a   Abel, S ^b   Maiers, M ^c   Flesch, S ^c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL MARROW DONOR PROGRAM   (United States)

Author keywords

Blood; Hematopoietic stem cell transplantation; HLA typing; Human leukocyte antigens; Transplantation; Umbilical cord

Indexed keywords

ARTICLE; BLOOD DISEASE; COHORT ANALYSIS; DONOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HLA MATCHING; HUMAN; PRIORITY JOURNAL; REGISTER; SIBLING; SICKLE CELL ANEMIA; THALASSEMIA; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VOLUNTEER;

ANEMIA, SICKLE CELL; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; REGISTRIES; THALASSEMIA; TISSUE DONORS;

EID: 0038743168     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703887     Document Type: Article

References (22)

1. Walters MC, Storb R, Patience M et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95: 1918-1924.
2. Lucarelli G, Galimberti M, Giardini C et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann NY Acad Sci 1998; 850: 270-275.
3. Walters MC, Patience M, Leisenring W et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996; 2: 100-104.
4. Gaziev D, Galimberti M, Lucarelli G et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant 2000; 25: 815-821.
5. La Nasa G, Giardini C, Argiolu F et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood 2002; 99: 4350-4356.
6. Crespo Chozas D, Maldonado Regalado MS, Munoz Villa A. Unrelated donor bone marrow transplantation in a girl with thalassemia major. Med Clin (Barc) 2000; 114: 598-599.
7. Contu L, La Nasa G, Arras M et al. Successful unrelated bone marrow transplantation in beta-thalassaemia. Bone Marrow Transplant 1994; 13: 329-331.
8. Cheng CN, Lu CC, Sun HF et al. Successful matched-unrelated bone marrow transplantation in a patient with Beta-thalassemia major. J Pediatr Hematol Oncol 2002; 24: 579-581.
9. Golden F. The sickle-cell kid. An experimental transplant succeeds, giving a brave little boy the best Christmas present he can imagine. Time 1999; 154: 92.
10. Sullivan KM, Anasetti C, Horowitz M et al. Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. Ann NY Acad Sci 1998; 850: 312-324.
11. Maiers M, Flesch S. Unrelated Donor Hematopoetic Stem Cell Transplantation for Hemoglobinopathies Facilitated by NMDP. National Marrow Donor Program: Minneapolis; 2002.
12. Krishnamurti L, Blazar BR, Wagner JE. Bone marrow transplantation without myeloablation for sickle cell disease. N Engl J Med 2001; 344: 68.
13. Schleuning M, Stoetzer O, Waterhouse C et al. Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. Exp Hematol 2002; 30: 7-10.
14. Chakraverty R, Peggs K, Chopra R et al. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood 2002; 99: 1071-1078.
15. Anasetti C, Petersdorf EW, Martin PJ et al. Improving availability and safety of unrelated donor transplants. Curr Opin Oncol 2000; 12: 121-126.
16. Gutoski M. Study verifies lack of ethnic diversity in bone marrow donors. Oncol Nurs Forum. 1995; 22: 717.
17. Freytes CO, Beatty PG. Representation of Hispanics in the National Marrow Donor Program. Bone Marrow Transplant 1996; 17: 323-327.
18. Yancey AK, Coppo P, Kawanishi Y. Progress in availability of donors of color: the National Marrow Donor Program. Transplant Proc 1997; 29: 3760-3765.
19. Antin JH, Childs R, Filipovich AH et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 tandem meetings. Biol Blood Marrow Transplant 2001; 7: 473-485.
20. Davies SM, DeFor TE, McGlave PB et al. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Am J Med 2001; 110: 339-346.
21. Mentzer WC. Bone marrow transplantation for hemoglobinopathies. Curr Opin Hematol 2000; 7: 95-100.
22. Confer DL. The National Marrow Donor Program. Meeting the needs of the medically underserved. Cancer 2001; 91: 274-278.